newsfilter
← Latest News
PR Newswire·

Cardinal Health report highlights cost savings and provider confidence in biosimilars

Cardinal Health (NYSE: CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician practices, which highlights...